Sen. Susan Collins’ hearing shines a much-needed light on a little-known problem.
health care
Posted inOp-eds, Opinion
Commentary: Data analysis useful in identifying Medicare fraud, but has limitations and requires caution
Prosecutors must take into account that certain physicians who prescribe medications or order patient procedures will stand out among their peers for perfectly innocent reasons.
advertisement
Posted inOp-eds, Opinion
State Rep. Golden: Voters have chance to expand vital home care options
A proposal on the ballot this fall would help prevent ill loved ones from being forced from their homes.
Posted inEditorials, Opinion
Another View: Empower generics makers to sue when Big Pharma won’t play ball
The government protects brand-name prescription medications from marketplace competition for anywhere from eight to more than 15 years.
Posted inBusiness, Health, Local & State, News
Mercy Hospital receives $2.8 million donation that honors ‘Dr. Harry’
The gift comes from the family of the late Dr. Harry Davis, Mercy’s first chief of pediatrics.
Posted inOp-eds, Opinion
The Maine Millennial: As Sen. McCain’s presence intersects with my life, I see our similarities
We may disagree on policy issues, but I suspect he would understand I love our country just as much as he does.
Posted inEditorials, Opinion
Another View: Successful right-to-die law finds itself on life support
A measure that’s helped even those who don’t take advantage of it is overturned in California.
Posted inEditorials, Opinion
Our View: ‘Opt-out’ fallout includes Westbrook chicken pox outbreak
A three-week quarantine for some day care charges shows the impact of forgoing immunizations.
Posted inHealth, Nation & World, News
FDA approves long-acting drug to prevent migraines
Aimovig, taken in a monthly shot, is the first in a new class of migraine drugs to win approval. It will cost $6,900 a year, without insurance.
Posted inBusiness
FDA names drugmakers accused of blocking cheaper generics
Regulators say some drugmakers use ‘gaming tactics’ to block cheaper copycat versions.